NeuroVision Imaging, Inc.
USPTO PatentsView assignee record - 9 granted patents across 5 technology areas, recorded in grant years 2016–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Neurovision ranks #29,583 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 5 technology areas.
- #29,583
- of 49,997 US assignees by volume
- 24th percentile
- by Innovation Score (27.5/100)
- 19.4
- avg claims per patent
- -100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R29583 · US Corporation #29,583 · 9 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 9 grants
- MID-PACK #29,583/49,997
- PHOTO-FINISH Netclearance Systems
- CPC-NARROW A61B · 5 areas
- INNOV-THIN 27.5/100
- CLAIMS-RICH 19.4 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Netclearance Systems, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Neurovision’s 27.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Neurovision
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- NeuroVision Imaging · this assignee 28
NeuroVision Imaging · this assignee
28 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Neurovision's Innovation Score is 27.5/100 (24th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Neurovision?
Each dot is one of Neurovision’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Neurovision’s own 19.4 claims/patent is ABOVE the 17.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Neurovision's grants concentrate
NeuroVision Imaging, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). By volume, Neurovision sits between Netclearance Systems, Inc. and New Standards Manufacturing Co..
Who files at NeuroVision's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Netclearance Syst…
Netclearance Systems, Inc.
9 patents
- Neuvector
NeuVector, Inc.
9 patents
- Neuren Pharmaceut…
Neuren Pharmaceuticals Limited
9 patents
- Neurolutions
NeuroLutions, Inc.
9 patents
- Neurocentria
Neurocentria, Inc.
9 patents
- Neutron Therapeut…
Neutron Therapeutics LLC
9 patents
- New Ideas Manufac…
New Ideas Manufacturing LLC
9 patents
- New Standards Man…
New Standards Manufacturing Co.
9 patents
- Neurovision Imagi… ◀
NeuroVision Imaging, Inc.
9 patents
What this shows NeuroVision holds 9 patents at rank #29,595, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near NeuroVision
By rank, the assignees closest to #29,595 in granted patent volume.
- Netclearance Systems, Inc. #29,591 · 9 patents
- NeuVector, Inc. #29,592 · 9 patents
- Neuren Pharmaceuticals Limited #29,593 · 9 patents
- NeuroLutions, Inc. #29,594 · 9 patents
- Neurocentria, Inc. #29,596 · 9 patents
- Neutron Therapeutics LLC #29,597 · 9 patents
- New Ideas Manufacturing LLC #29,598 · 9 patents
- New Standards Manufacturing Co. #29,599 · 9 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in NeuroVision's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Neurovision's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
28 24th percentile higher than 24% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 3 | 33.3% |
| 2017 | 3 | 33.3% |
| 2018 | 3 | 33.3% |
Which technologies does NeuroVision Imaging, Inc. patent most?
Top 5 of 5 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
NeuroVision Imaging, Inc.'s patent record in context - here's where to go next.
- NeuroVision Imaging, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #29,583 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare NeuroVision Imaging, Inc. against Netclearance Systems, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 27.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.